DarioHealth Corp. Secures $17.5 Million Through Private Placement of Common Stock
DarioHealth Corp., currently listed on NASDAQ under the ticker DRIO, has recently unveiled an impressive
private placement initiative. This strategic move allows the company to raise approximately
$17.5 million by selling
2,713,180 shares of common stock at a price of
$6.45 per share. This calculated approach not only strengthens Dario's financial positioning but also propels its mission to lead in the global
digital health market.
The anticipated closing date for this offering is set for
September 23, 2025, assuming all customary conditions are met. In line with maximizing advantages from this funding, DarioHealth plans to allocate the proceeds towards various
general corporate purposes.
This offering adheres to
exemption regulations under section 4(a)(2) of the
Securities Act of 1933 and involved regulations ensuring a compliance framework within state laws. However, it is essential to note that the securities involved may not be available for trade within the U.S. unless they comply with further regulatory requirements. DarioHealth has committed to registering these shares with the
Securities and Exchange Commission (SEC) for reselling.
About DarioHealth Corp.
DarioHealth Corp. is a transformative entity within the digital health sector, carving a unique niche with its comprehensive platform aimed at managing chronic health conditions. Through its tailor-made,
data-driven solutions, Dario facilitates personalized coaching and interventions that empower users to manage their health effectively, covering specific areas like
diabetes,
hypertension, and
behavioral health.
Rather than following the conventional episodic healthcare model, DarioHealth employs a
continuous care approach focused on enabling individuals to adapt their lifestyles sustainably. This innovative method enhances user satisfaction and retention, complementing their efforts towards achieving measurable health outcomes.
Dario's offerings cater to a diverse range of clients, including health plans, self-insured employers, and healthcare providers, ensuring wide accessibility to their acclaimed digital solutions. Interested parties looking for more information about DarioHealth can navigate to their website at
dariohealth.com for further insights.
Forward-Looking Statements
It's important to recognize the existence of
forward-looking statements in this announcement, particularly concerning the projected proceeds from the offering and intended use of the funds. Actual results may vary significantly due to factors such as regulatory components and market demands. Hence, readers are encouraged to consult Dario's SEC filings for a comprehensive understanding of potential risks that could alter results.
In an era where digital solutions are becoming increasingly essential, DarioHealth stands at the forefront of bringing innovative health management technology to users worldwide, emphasizing their commitment to revolutionizing chronic care management.
For inquiries, the DarioHealth Investor Relations arm can be reached via email or phone as provided in the original press release, solidifying transparency in their operations while inviting further dialogue regarding their growth trajectory.